100% LIVE       Sep 6-8, 2023
Parsippany, NJ Hilton

> 2019 Exhibitors

> 2018 Exhibitors

> 2015 Exhibitors

Download 2019 Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2015 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of December 09, 2022

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

Kalexsyn, Inc.
Key Organics
Kyongbo Pharmaceutical Co.

Kalexsyn, Inc., Booth 69 [ company website ]

Kalexsyn provides clients with proven, experienced medicinal chemists: IP-enabling SAR, custom synthesis, stable label synthesis, early API scale-up and process improvement. Full analytical capabilities onsite. We deliver:

  • Real medicinal chemistry: Medchem experience built from years of experiential practice.
  • Problem solving: Able to problem solve tough synthetic challenges in conjunction with clients. You can ask them.
  • Communication: Information provided in an agreed upon format, on time every time. Our international client base from Osaka to Vienna is reflective of our successful communication skills.

Key Organics, Booth 08 [ company website ]

Key Organics is a leading, global provider of chemistry-based services and products to the international biotechnology, pharmaceutical and agrochemical industries. With over 26 years expertise in synthetic organic chemistry, novel fragment design and collaborative services, Key Organics is the ideal partner of choice for challenging R&D projects. Our BIONET collection contains over 65,000 fragments, intermediates, biochemicals and drug templates.

Kyongbo Pharmaceutical Co., Booth 72 [ company website ]

Kyongbo Pharmaceutical Co., Ltd (Kyongbo), an affiliate of Chong Kun Dang pharmaceutical Corp., is a leading pharmaceutical company in Korea. Kyongbo is specialized in manufacturing APIs for Anti-infectives, Anti-hypertension, Anti-cardiovascular, targeted Anti- cancer and General APIs and etc. Kyongbo offers the customized CMO & CRO business (Clinical stage) to the multinational companies with integrated technical resources and dedicated facilities of Cephalosporins, Carbapenems and General APIs which are satisfied with cGMP standards. With constant efforts to be a qualified cGMP manufacturer, Kyongbo has 5 COS certified products in EU, 10 DMFs in USFDA and 47 APIs registered in PMDA of Japan. Kyongbo has “High-Potency 1” facility with isolation system dedicated to Cytotoxic Anti-cancer APIs. It is classified in Category 4 (SafeBridge OEL Categorization). Kyongbo is ready to be a suitable partner including CMO & CRO business through cGMP facilities including “High-Potency1”, and will be appropriate with your existing and future products.